UNODC estimates ~244M cannabis users in 2023. steady long-run demand with formal channels catching up.
Why it matters. Demand is not the constraint. Proof of quality and lawful distribution is. Source
You do not need more noise. You need the one page that tells you what moved, why it matters to you, and what to do next. NEXUS translates live market and regulatory signals into role-specific moves. You get clarity in minutes. You act with confidence.
A monthly decisions engine built around you
Real signals only. Live market and policy movement distilled to what affects you. Region-aware. Role-aware. Zero fluff.
A micro-playbook generated from your priority, your role, your region, and your notes. You get exact next steps, timelines, intros, and links that match your situation.
2–4 openings vetted for fit. Partnerships, pilots, procurement, investment. Each with a why, required resources, estimated impact, and a direct action.
Clean, current bullets on what changed, where, and what to adjust now. Source-linked. Ready to brief your team.
Hand-picked operators, regulators, or investors that match your intent. We handle the bridge. You focus on the deal.
Update your priority in seconds, and your next brief shifts with you. New signals flow in. Your plan stays current.
Policymakers and regulators. Align stakeholders. reduce friction. spot implementation risks early.
Operators and founders. Land market entry. compress compliance. accelerate partnerships.
Investors and family offices. Filter hype. find resilient assets. engage teams that ship.
Diaspora leaders and partners. Build credible bridges into the Caribbean and broader Global South.
We start in the Global South. We connect continents instead of copying one playbook.
We are ISC. We sit with regulators, operators, and capital every week.
Every block pushes toward a move. an intro, a document, a date, a metric.k.
Precision at scale. Editorially verified. Credibility guaranteed.
Profile. Investor . Region. Caribbean . Priority. Market Entry
Global signals reward operators who document quality. secure compliant distribution. and build cross-border partnerships. The UN reports cannabis remains the most used drug globally at ~244M users in 2023. a reminder that medical channels will tighten. audit trails will matter. and supply will professionalize.[1] In Europe. Germany’s medical framework advances with phased pilots. favoring clinical supply discipline and validated partners.[2] In the US. federal rescheduling moved forward in 2025. reshaping capital access and compliance exposure as states simultaneously crack down on intoxicating hemp derivatives that formed a multi-billion market.[3] [4]
“Dominica’s cannabis reform is a bridge between health. economy. and culture. We are building a responsible Caribbean innovation hub.”
Dr. Al-Mario Casimir . Dominica Cannabis Licensing Authority
Since your priority is Market Entry. assemble an audit-ready data room. map export scenarios with two banking rails. and co-design one clinical or wellness pilot. Treat interoperability across islands as a feature. not a boundary.
UNODC estimates ~244M cannabis users in 2023. steady long-run demand with formal channels catching up.
Why it matters. Demand is not the constraint. Proof of quality and lawful distribution is. Source
Germany proceeds with medical reforms and pilot projects. prioritizing patient access. pharmacovigilance. and validated supply.
Why it matters. EU buyers will favor traceable. compliant Caribbean partners. Source
Reply to request an ISC introduction.


A personalized monthly brief. One page. An ISC Editorial Brief grounded in facts. Your Focus This Month tailored to role and region. 2–4 actionable opportunities. a regulatory snapshot. and warm introductions on request. Frequency is monthly.
NEXUS is profile-aware and region-aware. It privileges Global South realities. It is built for decisions. Each point includes why it matters and a concrete next step. No fluff.
You provide role, region, monthly priority, and optional notes. Our engine selects relevant signals, then applies editorial review to generate a concise plan aligned with your objectives.
Yes. Regulatory items reference official or primary materials when available. Insights and opportunities include links when a public source exists. If a link is not available, we label it clearly.
You still get a regional snapshot with adjacent signals that affect you. We also suggest relevant introductions to close information gaps.
Yes. Update your priority in seconds. Your next brief reflects the change, and your current month’s action plan adapts accordingly.
We separate facts from interpretation. The ISC Editorial Brief uses only verifiable information. Editors enforce clarity, neutrality, and source discipline. No invented data.
We use your profile and notes to personalize your brief. No resale. Removal on request. Sensitive details are not required. We publish a clear privacy policy and adhere to it.
We separate facts from interpretation. The ISC Editorial Brief uses only verifiable information. Editors enforce clarity, neutrality, and source discipline. No invented data.